T L Hearn
Overview
Explore the profile of T L Hearn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
WILLIAMS L, Blumer S, Schalla W, Robinson P, Handsfield J, Fehd R, et al.
Transfusion
. 2001 Jan;
40(12):1514-21.
PMID: 11134573
Background: Since 1989, the CDC's Model Performance Evaluation Program has shipped samples to voluntary participant laboratories that test for HTLV antibodies. Each laboratory tests the well-characterized samples, reports the results,...
2.
St John T, Lipman H, Krolak J, Hearn T
Arch Pathol Lab Med
. 2000 Jul;
124(7):1066-73.
PMID: 10888785
Background: In 1986 and 1989, the Centers for Disease Control and Prevention sponsored institutes on Critical Issues in Health Laboratory Practice. It was noted during the institutes that physician's office...
3.
Keenlyside R, Collins C, Hancock J, Gagnon M, Cohn R, Menoff A, et al.
Am J Clin Pathol
. 1999 Dec;
112(6):769-76.
PMID: 10587699
We rescreened Papanicolaou smear slides from 40,245 women, which had been examined by 81 cytology screeners, scored the screeners' work performance, and compared these scores with the results of the...
4.
Astles J, Lipman H, Schalla W, Blumer S, Fehd R, Smith C, et al.
Arch Pathol Lab Med
. 1998 Aug;
122(8):700-7.
PMID: 9701331
Objective: To assess use of quality control (QC) material, supplemental to internal kit controls (calibrators), as protection against errors in enzyme immunoassay testing for human immunodeficiency virus type 1 antibodies....
5.
Stull T, Hearn T, Hancock J, Handsfield J, Collins C
JAMA
. 1998 Feb;
279(6):463-7.
PMID: 9466641
Context: Congress enacted the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to promote uniform quality and standards among all testing sites in the United States. The performance indicators specified in...
6.
Hearn T, Olsen M, Hunter R
Ann N Y Acad Sci
. 1996 Feb;
778:388-9.
PMID: 8610999
No abstract available.
7.
Cross G, Schalla W, Hancock J, Hearn T, Blumer S, Taylor R, et al.
Arch Pathol Lab Med
. 1992 May;
116(5):477-81.
PMID: 1580749
In 1986, a performance evaluation program at the Centers for Disease Control was implemented to assess the quality of performance of laboratories testing for human immunodeficiency virus type 1 antibody...
8.
Blumer S, Hearn T, Schalla W, Cross G, Valdiserri R
Arch Pathol Lab Med
. 1992 May;
116(5):471-6.
PMID: 1316110
In three performance evaluation surveys, panels that consisted of human T-lymphotropic virus type I or type II (HTLV-I/II) antibody-positive and -negative plasma samples were mailed to laboratories that voluntarily participated...
9.
Peddecord K, BENENSON A, Hofherr L, Garfein R, Francis D, Hewitt D, et al.
Clin Lab Sci
. 1992 Apr;
5(3):172-6.
PMID: 10147725
Blind proficiency testing was used to examine nonanalytic performance indicators for human immunodeficiency virus type 1 (HIV-1) antibody testing. Physician offices, clinics, and hospitals located throughout Southern California submitted simulated...
10.
Gerber A, Valdiserri R, Johnson C, Schwartz R, Hancock J, Hearn T
Arch Pathol Lab Med
. 1991 Nov;
115(11):1091-6.
PMID: 1747026
In May 1988, the Centers for Disease Control's Model Performance Evaluation Program (Atlanta, Ga) surveyed 1092 laboratories that performed enzyme immunoassays and Western blot tests for human immunodeficiency virus type...